TSX:ENGH - Post Discussion
Post by
retiredcf on Sep 20, 2024 8:40am
RBC
Their upside scenario target is $59.00. GLTA
Enghouse Systems Limited
Moving in the right direction
Our view: Enghouse's Q3 (fiscal quarter ended July) was slightly ahead of RBC/consensus. The upside stems from better than expected organic growth, which reached the highest level in 4 years and was above Enghouse's 10-year historical average. We see attractive risk-reward on the shares, considering valuation at trough levels (8.6x EBITDA), stabilizing organic growth, and M&A likely to ramp going forward. Maintain Outperform, $43.00 price target.
Key points:
• Q3 above RBC/consensus. Q3 revenue of $131MM (18% Y/Y) exceeded our estimate of $128MM (consensus: $130MM) on better than expected organic growth. Due to higher revenue and lower opex, adj. EBITDA of $38MM (13% Y/Y) exceeded RBC/consensus of $36MM. IFRS EPS of $0.37 was slightly above RBC/consensus of $0.36/$0.34.
-
Organic growth reaches the highest level in 4 years. We estimate that constant currency (CC) organic growth was -2% Q3, above the -4% in our model and up from -4% Q2. Organic growth is the highest since Q3/ FY20 and is above Enghouse's 10-year historical average (-3%). Enghouse indicated that it is seeing traction of its "choice" strategy to offer both SaaS and on-premise; Q3 was one of Enghouse's strongest quarters for new order bookings and recurring hosted & maintenance was up 23% Y/ Y, faster than total revenue.
-
M&A is a potential catalyst. Management is upbeat that there are a large number of acquisition opportunities in the market. Enghouse has deployed $70MM capital on acquisitions TTM, up from $43MM in the prior TTM period. The company is disciplined and appears to be waiting for sellers to meet its expectations. With cash near record highs ($259MM Q3) and our outlook for Enghouse to generate $122MM NTM FCF, we believe M&A is a potential catalyst for the stock. We estimate every $100MM deployed on acquisitions is 17% accretive to annual adj. EPS.
-
Buybacks are another potential use of cash. In light of Enghouse's cash and the low valuation of the stock (at 8.6x NTM EV/EBITDA), management suggested that the company could increase the pace of share buybacks. Enghouse has repurchased 134k shares YTD under its current NCIB (maximum 3.0MM shares or 6.9% of float until May 2025).
-
Discounted valuation doesn’t reflect Enghouse's long-term track record of compounding capital. Enghouse is trading 61% below peers at 22x and 42% below its 10-year average (15x). Enghouse has a strong track record of allocating capital at high rates, which has driven a 12% FCF/share CAGR over the last 10 years. We believe risk-reward on the shares is attractive given Enghouse’s discounted valuation, stabilizing organic growth, and our outlook for M&A to meaningfully ramp over the next 12-18 months. Our $43.00 price target is unchanged and remains based on 13x CY25e EV/EBITDA.
Be the first to comment on this post